Sublingual immunotherapy for allergic rhinitis: an update

Current Opinion in Otolaryngology and Head & Neck Surgery, 01/25/2011

The dose dependency of the efficacy of Sublingual immunotherapy and the optimal maintenance dose have been identified at least for grass allergens. The safety is well demonstrated in both adults and children.

Print Article Summary Cat 2 CME Report